A Phase II Clinical and Translational Study of MK-2206 in Patients with Metastatic Neuroendocrine Tumors (NETs)

被引：0
|
作者：
Reidy-Lagunes, Diane [1 ,2 ]
Pietanza, M. Catherine [1 ,2 ]
Sega, Michal [1 ,2 ]
Capanu, Marinela [1 ,2 ]
Saltz, Leonard [1 ,2 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA
来源：
PANCREAS | 2014年 / 43卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：503 / 503
页数：1
相关论文
共 50 条
  • [1] A phase II clinical and translational study of MK-2206 in patients with metastatic neuroendocrine tumors (NETs).
    Reidy, Diane Lauren
    Pietanza, Maria Catherine
    Segal, Michal
    Capanu, Marinela
    Saltz, Leonard
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [2] A phase I trial of MK-2206 and hydroxychloroquine in patients with advanced solid tumors
    Mehnert, Janice M.
    Kaveney, Amanda D.
    Malhotra, Jyoti
    Spencer, Kristen
    Portal, Daniella
    Goodin, Susan
    Tan, Antoinette R.
    Aisner, Joseph
    Moss, Rebecca A.
    Lin, Hongxia
    Bertino, Joseph R.
    Gibbon, Darlene
    Doyle, Laurence A.
    White, Eileen P.
    Stein, Mark N.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2019, 84 (04) : 899 - 907
  • [3] A phase I trial of MK-2206 and hydroxychloroquine in patients with advanced solid tumors
    Janice M. Mehnert
    Amanda D. Kaveney
    Jyoti Malhotra
    Kristen Spencer
    Daniella Portal
    Susan Goodin
    Antoinette R. Tan
    Joseph Aisner
    Rebecca A. Moss
    Hongxia Lin
    Joseph R. Bertino
    Darlene Gibbon
    Laurence A. Doyle
    Eileen P. White
    Mark N. Stein
    Cancer Chemotherapy and Pharmacology, 2019, 84 : 899 - 907
  • [4] A phase I study of MK-2206 in combination with lapatinib in patients (pts) with advanced solid tumors.
    Wisinski, Kari Braun
    Tevaarwerk, Amye
    Bell, Maria
    Burkard, Mark E.
    Eickhoff, Jens C.
    Wilding, George
    LoConte, Noelle K.
    Traynor, Anne M.
    Hoang, Tien
    Heideman, Jennifer
    Kolesar, Jill
    Liu, Glenn
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [5] A phase II study of MK-2206, an AKT inhibitor, in uterine serous carcinoma
    Stover, Elizabeth H.
    Xiong, Niya
    Myers, Andrea P.
    Tayob, Nabihah
    Engvold, Victoria
    Polak, Madeline
    Broaddus, Russell R.
    Makker, Vicky
    Drapkin, Ronny
    Liu, Joyce F.
    Horowitz, Neil S.
    Meric-Bernstam, Funda
    Aghajanian, Carol
    Coleman, Robert L.
    Mills, Gordon B.
    Cantley, Lewis C.
    Matulonis, Ursula A.
    Westin, Shannon N.
    Konstantinopoulos, Panagiotis A.
    GYNECOLOGIC ONCOLOGY REPORTS, 2022, 40
  • [6] PHASE 1 STUDY OF THE SELECTIVE AKT INHIBITOR MK-2206 IN JAPANESE PATIENTS WITH ADVANCED SOLID TUMORS
    Tanabe, Y.
    Doi, T.
    Tamura, K.
    Yonemori, K.
    Kodaira, M.
    Fuse, N.
    Bando, H.
    Maeda, Y.
    Shimamoto, T.
    Ohtsu, A.
    ANNALS OF ONCOLOGY, 2012, 23 : 164 - 164
  • [7] SU2C Phase Ib Study of Paclitaxel and MK-2206 in Advanced Solid Tumors and Metastatic Breast Cancer
    Gonzalez-Angulo, Ana M.
    Krop, Ian
    Akcakanat, Argun
    Chen, Huiqin
    Liu, Shuying
    Li, Yisheng
    Culotta, Kirk S.
    Tarco, Emily
    Piha-Paul, Sarina
    Moulder-Thompson, Stacy
    Velez-Bravo, Vivianne
    Sahin, Aysegul A.
    Doyle, Laurence A.
    Do, Kim-Anh
    Winer, Eric P.
    Mills, Gordon B.
    Kurzrock, Razelle
    Meric-Bernstam, Funda
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2015, 107 (03):
  • [8] Results of an abbreviated phase-II study with the Akt Inhibitor MK-2206 in Patients with Advanced Biliary Cancer
    Ahn, Daniel H.
    Li, Junan
    Wei, Lai
    Doyle, Austin
    Marshall, John L.
    Schaaf, Larry J.
    Phelps, Mitch A.
    Villalona-Calero, Miguel A.
    Bekaii-Saab, Tanios
    SCIENTIFIC REPORTS, 2015, 5
  • [9] A Phase I Study of Dinaciclib in Combination With MK-2206 in Patients With Advanced Pancreatic Cancer
    Murphy, Adrian G.
    Zahurak, Marianna
    Shah, Mirat
    Weekes, Colin D.
    Hansen, Aaron
    Siu, Lillian L.
    Spreafico, Anna
    LoConte, Noelle
    Anders, Nicole M.
    Miles, Tearra
    Rudek, Michelle A.
    Doyle, L. Austin
    Nelkin, Barry
    Maitra, Anirban
    Azad, Nilofer S.
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2020, 13 (06): : 1178 - 1188
  • [10] Results of an abbreviated phase-II study with the Akt Inhibitor MK-2206 in Patients with Advanced Biliary Cancer
    Daniel H. Ahn
    Junan Li
    Lai Wei
    Austin Doyle
    John L. Marshall
    Larry J. Schaaf
    Mitch A. Phelps
    Miguel A. Villalona-Calero
    Tanios Bekaii-Saab
    Scientific Reports, 5
12345